Ombretta Turriziani
Ombretta Turriziani is an expert in Infectiology at Policlinico Umberto I (Italy). Ombretta Turriziani has authored 208 publications, the most recent in 2026, and is an investigator in 1 clinical trial. SLR score: 503 (community average: 125). How the SLR is computed.
LeadR Profile
Infectiology
Subspecialties: Immunology - Public Health - Pharmacy
Main Topics
Publications and Clinical Studies
Profile data updated on
Organizations
Career arc: 1993 - 2026
Number : 208
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Genomic evolution and minority variant dynamics of RSV during the first season of nirsevimab implementation in Italy (2024-5). PMID 42592280 — genetic variation, genes, respiratory syncytial viruses, quasispecies, genome, mutation | Virus Evol | 2026 | 0 |
| Diagnosis of Respiratory Infections Using Syndromic Panels: A Ct-Based Approach Beyond Qualitative Detection. PMID 42513956 — respiratory tract infections, viruses, diagnosis, infections | Microorganisms | 2026 | 0 |
| SARS-CoV-2 mRNA Vaccination Induces Neutralizing Antibodies and Type I IFN Changes in People Living With HIV. PMID 42504161 — cells, genes, sars-cov-2, vaccines, antibodies, rna, messenger, antibodies, neutralizing, vaccination, hiv, viruses, cell count, severe acute respiratory syndrome-related coronavirus, gene expression | J Med Virol | 2026 | 0 |
| Long-Acting Cabotegravir/Rilpivirine Reduces Immune-Activation and -Senescence in People With HIV With CMV Co-Infection. PMID 42300985 — cells, flow cytometry, coinfection, hiv, rilpivirine, immunity, infections | Immunology | 2026 | 0 |
| Analysis of Torquetenovirus DNA levels in NSCLC patients treated with immune checkpoint inhibitors. PMID 42139225 — neoplasms, carcinoma, non-small-cell lung, viral load, immunotherapy, immune checkpoint inhibitors, therapeutics, dna | PLoS One | 2026 | 0 |
Clinical Studies 1
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Main Topics
Cohort/Consortium Investigators 7
LeadR Networks
Main global connection map